ISPOR Europe 2023 Home
  • About
    • News Center
  • Award Winners
  • Program
    • Program
    • Student Program
    • Learning Formats
    • Plenary Sessions
    • Posters
    • Program Committee
    • Digital Conference Pass
  • Exhibits & Sponsorship
    • Sponsor List
    • Exhibitor Directory
    • Media Partners
  • Photo Gallery
large-circle

ISPOR Europe 2023

12 - 15 November

  • Home
  • Events
  • Past Conferences
  • ISPOR Europe 2023
  • Program
  • Program
  • Session

  • Physician Reported Treatment Attributes Considered in First-Line and Perceptions Around Bruton Tyrosine Kinase Inhibitor (BTKi) Treatments in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) in the US

    Nov 14, 2023, 10:30 AM
  • «
  • 1181 (current)
  • 1182
  • 1183
  • 1184
  • 1185
  • 1186
  • 1187
  • 1188
  • 1189
  • 1190
  • »
Quick Links
  • Membership
  • Upcoming Conferences & Events
  • Exhibits & Sponsorships
  • Good Practices Reports & More
  • Value in Health
  • Contact Us
Policies & Legal
  • Antitrust Compliance
  • Code of Ethics
  • Diversity Policy
  • Funding Statement
  • Legal Disclaimer
  • Privacy Policy
  • Cookie Policy
  • Terms and Conditions

Site Map

Media/Press

ISPOR–The Professional Society for
Health Economics and Outcomes Research

Copyright © 2018 ISPOR. All rights reserved.

International Society for Pharmacoeconomics and Outcomes Research, Inc

Website Design & Development by Matrix Group